---
title: "Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. (UPC CoA 402/2024, 20-12-2024)"
description: "The Court of Appeal refused Alexion a preliminary injunction against Samsung Bioepis' eculizumab biosimilar Epysqli."
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-402-2024-2024-12-20
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:16.462Z
dateModified: 2026-11-18T10:07:16.462Z
---

# Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.

Order of the UPC Court of Appeal of 20 December 2024, UPC CoA 402/2024.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal refused Alexion a preliminary injunction against Samsung Bioepis' eculizumab biosimilar Epysqli. A patent claim containing an apparent error (here a light-chain sequence that includes a 22-amino-acid signal peptide) can be read as corrected only if both the error and the exact correction are sufficiently certain to the skilled person. Read literally, the claim was more likely than not insufficiently disclosed under Art 83 EPC, so its validity was not sufficiently certain.

## Key holding

A linguistic error, a spelling mistake or any other inaccuracy in a patent claim can be corrected by way of claim interpretation only if the existence of the error and the precise way to correct it are sufficiently certain to the average skilled person. That certainty must follow from the claim, read with the description and drawings and using common general knowledge. This is a rather strict standard, because an error as such implies legal uncertainty for third parties. The applicant's assertions during grant proceedings, and in particular their endorsement by the EPO Technical Board of Appeal, can indicate the skilled person's view at the filing date.

## Questions decided

1. When can an error in a patent claim be corrected by claim interpretation?
2. Do a patentee's grant-proceedings assertions, endorsed by the TBA, inform the skilled person's view?
3. Does a statistical prediction of a signal-peptide cleavage site establish the precise correction of a claimed sequence?
4. Was the validity of claim 2 sufficiently certain to grant provisional measures?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 1a
- Panel: Klaus Grabinski (President of the Court of Appeal); Peter Blok (legally qualified judge and judge-rapporteur); Emmanuel Gougé (legally qualified judge); Eric Enderlin (technically qualified judge); Anna Hedberg (technically qualified judge)
- Date: 20-12-2024
- Case number(s): UPC CoA 402/2024, UPC CFI 123/2024
- Parties: Appellant: Alexion Pharmaceuticals, Inc. (applicant at first instance); Respondent: Samsung Bioepis NL B.V. (defendant at first instance)
- Language of the proceedings: English
- Outcome: The appeal is rejected. Alexion must bear the costs of the appeal proceedings.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/137906F1C2EFE52C187C75D4F7CD8202_en.pdf

## How to cite

Court of Appeal, Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V., UPC CoA 402/2024, Order of 20 December 2024 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-402-2024-2024-12-20

Topics: [Provisional measures](https://pitch.law/academy/upc-court-of-appeal/topics/provisional-measures), [Infringement and claim interpretation](https://pitch.law/academy/upc-court-of-appeal/topics/infringement)

## In the same case

- [Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V., UPC CoA 402/2024, 30-07-2024](https://pitch.law/academy/upc-court-of-appeal/upc-coa-402-2024-2024-07-30): The Court of Appeal refused to expedite an appeal against the dismissal of an application for provisional measures.

## More on provisional measures

- [Guardant Health, Inc. v Sophia Genetics SA and others, UPC CoA 49/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-49-2026-2026-11-05): The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- [SharkNinja Operating LLC v Groupe SEB France and others, UPC CoA 61/2026, 21-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-61-2026-2026-08-21): The Court of Appeal overturned the Paris Local Division and granted SharkNinja a provisional injunction in France and Germany against SEB's "Cookeo Infinity" multicookers.
- [Amazon.com, Inc. and others v InterDigital VC Holdings, Inc. and others, UPC CoA 936/2025, 15-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-936-2025-2026-07-15): The Court of Appeal permitted InterDigital to withdraw its application for provisional measures against Amazon while Amazon's appeal was pending, and declared the proceedings closed.
- [AIM Sport Development AG v TGI Sport Suomi Oy and others, UPC CoA 108/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-108-2026-2026-07-08): The Court of Appeal's judge-rapporteur held that an appeal against a first-instance order disposing of an application for provisional measures is an appeal against a final decision under R 220.1(a) RoP, because R 363.2 RoP gives such orders that status.
- [Angelalign Technology Inc. and others v Align Technology, Inc., UPC CoA 36/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-36-2026-2026-07-08): The Court of Appeal rejected Angelalign's appeal and upheld the Düsseldorf preliminary injunction against the "Live Now" feature of its iOrtho orthodontic planning software.
